No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
QTRX Quanterix
- 13.780
- -0.270-1.92%
Close Jun 18 16:00 ET
- 13.540
- -0.240-1.74%
Post 18:26 ET
527.36MMarket Cap-14354P/E (TTM)
14.440High13.710Low402.32KVolume14.020Open14.050Pre Close5.60MTurnover1.20%Turnover RatioLossP/E (Static)38.27MShares29.70052wk High1.54P/B464.06MFloat Cap13.09052wk Low--Dividend TTM33.68MShs Float92.570Historical High--Div YieldTTM5.20%Amplitude6.310Historical Low13.917Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
PDF Version BILLERICA, Mass.--(BUSINESS WIRE)--Jun. 17, 2024-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today annou
Quanterix Down Over 14%, on Pace for Largest Percent Decrease Since August 2022 -- Data Talk
Quanterix Corporation (QTRX) is currently at $15.26, down $2.51 or 14.12% --Would be lowest close since May 2, 2023, when it closed at $12.27 --On pace for largest percent decrease since Aug. 9, 202
Form 144 | Quanterix(QTRX.US) Director Proposes to Sell 378.14K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 12, $Quanterix(QTRX.US)$ Director LAURIE OLSON intends to sell 20,915 shares of its common stock on Jun 12, with a total market value of approximately $378.14K. LAURIE OL
CCORF Maintains Quanterix(QTRX.US) With Buy Rating, Maintains Target Price $25
CCORF analyst Kyle Mikson CFA maintains $Quanterix(QTRX.US)$ with a buy rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 22.0% and a total av
Scotiabank Maintains Quanterix(QTRX.US) With Buy Rating, Maintains Target Price $32
Scotiabank analyst Sung Ji Nam maintains $Quanterix(QTRX.US)$ with a buy rating, and maintains the target price at $32.According to TipRanks data, the analyst has a success rate of 45.2% and a total a
Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation
Comments
The insider transactions over the last year suggest optimism about the company's future. The level of insider ownership indicates a reasonable degree of alignment with common shareholders.
One Quanterix Insider Raised Their Stake In The Previous Year
ABOS PEPG TOPS AAPL DIS XPEV MNMD TSM QTRX
$Acumen Pharmaceuticals(ABOS.US$ $PepGen(PEPG.US$ $Top Ships(TOPS.US$ $Apple(AAPL.US$ $Disney(DIS.US$ $XPeng(XPEV.US$ $Mind Medicine(MNMD.US$ $Taiwan Semiconductor(TSM.US$ $Quanterix(QTRX.US$
1
2
Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
21
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg